ChromoCare

Recent Finacing

Equity

Recent Raise

Undisclosed

ChromoCare provides the G•A•P Test, a 24-gene algorithm that assesses compatibility with 350+ medications, and is developing ChromoALERT, a genetic addiction-susceptibility platform for pain management.

Founded 2014

Ohio, United States

11-50

Private

chromocare.com

Highlights

Focus Areas

Biotechnology

Genetics

Health Care

Health Diagnostics

Precision Medicine

Financials

1

Funding round

Team

Upgrade to view the team

See the team members at ChromoCare.